For: | Kinoshita O, Ichikawa D, Ichijo Y, Komatsu S, Okamoto K, Kishimoto M, Yanagisawa A, Otsuji E. Histological evaluation for chemotherapeutic responses of metastatic lymph nodes in gastric cancer. World J Gastroenterol 2015; 21(48): 13500-13506 [PMID: 26730161 DOI: 10.3748/wjg.v21.i48.13500] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i48/13500.htm |
Number | Citing Articles |
1 |
Y. Hao, Y. Liu, H. Ishibashi, S. Wakama, E. Nishino, Y. Yonemura. Downstaging of lymph node metastasis after neoadjuvant intraperitoneal and systemic chemotherapy in gastric carcinoma with peritoneal metastasis. European Journal of Surgical Oncology 2019; 45(8): 1493 doi: 10.1016/j.ejso.2019.03.011
|
2 |
Liucheng Wu, Zhaoqiong Xing, Mingwei Huang, Hongping Yu, Yuzhou Qin, Qinwen Jin, Zihan Zhou, Jiansi Chen. Nodal downstaging to ypN0 after neoadjuvant chemotherapy positively impacts on survival of cT4N+ GC/GEJ patients. Journal of Surgical Oncology 2022; 126(8): 1403 doi: 10.1002/jso.27065
|
3 |
Maria Antonietta Mazzei, Giulio Bagnacci, Francesco Gentili, Andrea Nigri, Veronica Pelini, Carla Vindigni, Francesco Giuseppe Mazzei, Gian Luca Baiocchi, Frida Pittiani, Paolo Morgagni, Enrico Petrella, Gianni Mura, Beatrice Verdelli, Maria Bencivenga, Simone Giacopuzzi, Daniele Marrelli, Franco Roviello, Luca Volterrani. Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/1794524
|
4 |
Patricia Martin-Romano, Jose J Sola, Juan A Diaz-Gonzalez, Ana Chopitea, Yohana Iragorri, Fernando Martínez-Regueira, Mariano Ponz-Sarvise, Leire Arbea, Jose C Subtil, David Cano, Lucia Ceniceros, Jairo Legaspi, Jose Luis Hernandez, Javier Rodríguez. Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer. British Journal of Cancer 2016; 115(6): 655 doi: 10.1038/bjc.2016.252
|
5 |
Cas de Jongh, Lianne Triemstra, Arjen van der Veen, Lodewijk A. A. Brosens, Misha D. P. Luyer, Jan H. M. B. Stoot, Jelle P. Ruurda, Richard van Hillegersberg, Hylke J. F. Brenkman, Maarten F. J. Seesing, Grard A. P. Nieuwenhuijzen, Jeroen E. H. Ponten, Juul J. W. Tegels, Karel W. E. Hulsewe, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Wobbe O. de Steur, Henk H Hartgrink, Ewout A. Kouwenhoven, Marc J van Det, Eelco B Wassenaar, P. van Duijvendijk, Werner A. Draaisma, Ivo A. M. J. Broeders, Donald L. van der Peet, Suzanne S. Gisbertz. Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial. Gastric Cancer 2022; 25(6): 1060 doi: 10.1007/s10120-022-01329-2
|
6 |
Andrianos Tsekrekos, Michael Vieth, Nelson Ndegwa, Adrian Bateman, Jean-François Flejou, Heike I. Grabsch, Luca Mastracci, Sybren L. Meijer, Luca Saragoni, Kieran Sheahan, Jayant Shetye, Rhonda Yantiss, Lars Lundell, Sönke Detlefsen. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes. Human Pathology 2021; 116: 94 doi: 10.1016/j.humpath.2021.07.003
|
7 |
Xinxing Li, Weigang Zhang, Xianwen Zhang, Haolu Wang, Kai Xu, Houshan Yao, Jun Yao, Xiaowen Liang, Zhiqian Hu. The prognostic value of negative lymph node count for patients with gastric cancer who received preoperative radiotherapy. Oncotarget 2017; 8(29): 46946 doi: 10.18632/oncotarget.14943
|
8 |
Guillaume Levenson, Thibault Voron, François Paye, Pierre Balladur, Clotilde Debove, Najim Chafai, Alba Gallego De Dios, Jeremie H. Lefevre, Yann Parc. Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinoma. Surgery 2021; 170(6): 1711 doi: 10.1016/j.surg.2021.08.021
|
9 |
Bo Gao, Zehua Zhao, Xiaozhuo Gao, Tao Zhang, Ning Zhang, Yong Zhang, Yanmei Zhu. Role of pathological tumor regression grade of lymph node metastasis following neoadjuvant chemotherapy in locally advanced gastric cancer. Digestive and Liver Disease 2024; 56(10): 1768 doi: 10.1016/j.dld.2024.05.011
|
10 |
F. Pardo, J. Osorio, C. Miranda, S. Castro, M. Miró, A. Luna, E. Garsot, D. Momblán, G. Galofré, J. Rodríguez-Santiago, M. Pera. A real-life analysis on the indications and prognostic relevance of perioperative chemotherapy in locally advanced resectable gastric adenocarcinoma. Clinical and Translational Oncology 2020; 22(8): 1335 doi: 10.1007/s12094-019-02261-1
|
11 |
Daniel Reim, Alexander Novotny, Helmut Friess, Julia Slotta‐Huspenina, Wilko Weichert, Katja Ott, Bastian Dislich, Sylvie Lorenzen, Karen Becker, Rupert Langer. Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas. The Journal of Pathology: Clinical Research 2020; 6(4): 263 doi: 10.1002/cjp2.169
|
12 |
Yong Sun, Chao Chen, Lei Hou, Enhong Zhao. Short-term and long-term outcomes of patients with gastric cancer during versus before the COVID-19 pandemic: cohort study using propensity score matching method. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11441-w
|
13 |
Li-Yan Xue, Lin Yang, Jiang-Ying Yue, Xue-Min Xue, Yong-Kun Sun, Yue-Lu Zhu. Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy. World Journal of Gastrointestinal Oncology 2019; 11(1): 48-58 doi: 10.4251/wjgo.v11.i1.48
|
14 |
Qing Feng, Du Long, Ming-shan Du, Xiao-song Wang, Zhen-shun Li, Yong-liang Zhao, Feng Qian, Yan Wen, Pei-wu Yu, Yan Shi. Short-Term Clinical Efficacy of Neoadjuvant Chemotherapy Combined With Laparoscopic Gastrectomy for Locally Advanced Siewert Type II and III Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Propensity Score-Matched Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.690662
|